Pediatrix Medical Group, Inc. (NYSE:MD) Shares Purchased by Trexquant Investment LP

Trexquant Investment LP boosted its position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 112.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 431,230 shares of the company's stock after acquiring an additional 227,825 shares during the quarter. Trexquant Investment LP owned 0.50% of Pediatrix Medical Group worth $5,658,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in MD. Nomura Asset Management Co. Ltd. raised its stake in Pediatrix Medical Group by 95.3% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after acquiring an additional 1,220 shares in the last quarter. Parkside Financial Bank & Trust boosted its position in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after purchasing an additional 1,040 shares during the period. Quarry LP increased its position in Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company's stock worth $55,000 after buying an additional 1,662 shares during the period. AlphaQuest LLC lifted its stake in Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after buying an additional 2,012 shares during the last quarter. Finally, Smartleaf Asset Management LLC boosted its stake in Pediatrix Medical Group by 750.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after purchasing an additional 6,090 shares during the period. Hedge funds and other institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Price Performance

Shares of NYSE:MD traded down $0.58 on Thursday, hitting $13.52. The company had a trading volume of 131,720 shares, compared to its average volume of 836,608. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The company has a market cap of $1.16 billion, a PE ratio of -11.19, a PEG ratio of 1.74 and a beta of 1.32. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $17.67. The business has a 50 day moving average of $14.35 and a 200 day moving average of $13.87.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company had revenue of $502.36 million during the quarter, compared to analysts' expectations of $486.22 million. As a group, equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on MD shares. Macquarie began coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $18.00 target price on the stock. Truist Financial raised their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research note on Friday, February 21st. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Finally, UBS Group raised their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a report on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Pediatrix Medical Group has an average rating of "Hold" and a consensus price target of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.